{"id":"lactobacillus-brevis-cd2-lozenges","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Oral irritation"},{"rate":null,"effect":"Allergic reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This live biotherapeutic product delivers viable Lactobacillus brevis CD2 bacteria via oral lozenge formulation, allowing direct contact with oral mucosa and subsequent colonization of the respiratory tract. The mechanism involves stimulation of innate and adaptive immune responses through pattern recognition receptors, enhancement of barrier function, and production of antimicrobial compounds and immunomodulatory metabolites.","oneSentence":"Lactobacillus brevis CD2 is a probiotic lozenge that colonizes the oral and respiratory tract to modulate local and systemic immune responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:18:15.151Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory tract infections (prevention or treatment)"},{"name":"Oral health / periodontal disease"}]},"trialDetails":[{"nctId":"NCT04398511","phase":"PHASE2","title":"L Brevis for Traumatic Oral Lesions in Orthodontic Patients","status":"COMPLETED","sponsor":"Universidade de Passo Fundo","startDate":"2019-01-07","conditions":"Orthodontic Appliance Complication, Oral Mucositis, Bacterium; Agent","enrollment":20},{"nctId":"NCT01545687","phase":"PHASE3","title":"CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy","status":"WITHDRAWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2012-04","conditions":"Head and Neck Cancer, Oral Complications of Radiation Therapy, Pain","enrollment":""},{"nctId":"NCT02329353","phase":"PHASE3","title":"Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers","status":"COMPLETED","sponsor":"Next Gen Pharma India Pvt. Ltd.","startDate":"2015-02","conditions":"Chronic Periodontitis","enrollment":60},{"nctId":"NCT02390687","phase":"PHASE3","title":"Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients","status":"COMPLETED","sponsor":"Next Gen Pharma India Pvt. Ltd.","startDate":"2015-04","conditions":"Chronic Periodontitis","enrollment":31},{"nctId":"NCT02203812","phase":"PHASE3","title":"Effect of Probiotic Lozenge on Gingivitis and Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2015-01","conditions":"Mild and Moderate Chronic Periodontitis","enrollment":32},{"nctId":"NCT02121665","phase":"PHASE3","title":"Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2014-07","conditions":"Chronic Periodontitis","enrollment":42},{"nctId":"NCT02357771","phase":"PHASE3","title":"Probiotic Lozenge Reduce Streptococcus Mutans in Plaque in Orthodontic Bracket Patients","status":"COMPLETED","sponsor":"Next Gen Pharma India Pvt. Ltd.","startDate":"2015-04","conditions":"Malocclusion","enrollment":30},{"nctId":"NCT02174757","phase":"PHASE3","title":"Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2014-08","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT01870362","phase":"PHASE3","title":"Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2013-06","conditions":"Chronic Periodontitis","enrollment":28},{"nctId":"NCT01707641","phase":"PHASE4","title":"Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer","status":"UNKNOWN","sponsor":"S. Andrea Hospital","startDate":"2012-11","conditions":"Mucositis","enrollment":140},{"nctId":"NCT02085694","phase":"PHASE2, PHASE3","title":"Lactobacillus Brevis CD2 Preventing Oral Mucositis","status":"UNKNOWN","sponsor":"Catholic University of the Sacred Heart","startDate":"2014-03","conditions":"Mucositis","enrollment":10},{"nctId":"NCT01778699","phase":"PHASE4","title":"Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2).","status":"UNKNOWN","sponsor":"Università degli Studi di Sassari","startDate":"2013-02","conditions":"Dental Caries, Gingivitis","enrollment":440},{"nctId":"NCT01601145","phase":"PHASE4","title":"Effect of Probiotic on the Plaque pH. A Randomized Double Blind Interventional Study","status":"COMPLETED","sponsor":"Università degli Studi di Sassari","startDate":"2012-01","conditions":"Plaque Ph Lowering After Use of Probiotics, Caries, Gingivitis","enrollment":192}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Probiotics"],"phase":"phase_3","status":"active","brandName":"Lactobacillus brevis CD2 Lozenges","genericName":"Lactobacillus brevis CD2 Lozenges","companyName":"Next Gen Pharma India Pvt. Ltd.","companyId":"next-gen-pharma-india-pvt-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lactobacillus brevis CD2 is a probiotic lozenge that colonizes the oral and respiratory tract to modulate local and systemic immune responses. Used for Respiratory tract infections (prevention or treatment), Oral health / periodontal disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}